Dapoxetine hydrochloride
- Level
- Commodity
- Parent
- 51292000
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51292021This classification denotes a selective serotonin reuptake inhibitor and antidepressant agent with the molecular formula C21H23NO.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier U4OHT63MRI, chemically known as (+)-(s)-n,n-dimethyl-alpha-(2-(1-naphthyloxy)ethyl)benzylamine hydrochloride but more generally known as dapoxetine hydrochloride, which bears US NIH Compound Identifier 71352. European Medicines Agency schedules Dapoxetine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB30408. Most nations, for tariff and trade purposes, schedule dapoxetine hydrochloride under HS 29221980 and SITC 51461. As of Q4 2014, DAPOXETINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Dapoxetine hydrochloride bears US NLM identifiers UMLS ID C0970823 and NCI Concept Code C76101. SMILES: CN(C)[C@@H](CCOC1CCCC2C1CCCC2)C3CCCCC3.CL.
Same parent
Under 51292000 · 29Activities that produce or sell this
KBLI · 8Inherited from family 51290000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.